# Treatment methods for Primary Lateral Sclerosis
Primary lateral sclerosis (PLS) is a rare neurodegenerative disorder in which the upper motor neurons in the motor cortex and spinal cord are particularly affected. Because the disease progresses slowly and there is considerable variability between patients, treatment is aimed at slowing symptoms, maintaining strength and movement, and supporting quality of life. The following treatments are applied, each with their own place in the disease process.
Medications that influence progression
Riluzole ProveniIncluded in official guidelines, or approved by EMA or FDA
Riluzole is a medication that reduces the release of the neurotransmitter glutamate. In motor brain regions, excess glutamate can be harmful to nerve cells. Riluzole is approved and is listed in international guidelines as a first treatment option for ALS and is also investigated and used in PLS. It works by probably inhibiting glutamate transmission.
Known common side effects include fatigue, nausea and headache. Sometimes liver enzymes can change, which is why this is monitored through blood tests.
Edaravone ProveniIncluded in official guidelines, or approved by EMA or FDA
Edaravone is an antioxidant that neutralizes free radicals (harmful molecules) in nerve cells. It is approved for ALS and is also used in research and clinical practice for PLS. Edaravone is administered by injection.
Common side effects are reactions at the injection site, fever and muscle pain.
Spasticity and muscle tone
Baclofen ProveniIncluded in official guidelines, or approved by EMA or FDA
Baclofen is a GABA agonist that reduces muscle tension. Because PLS primarily affects upper motor neurons, this leads to increased muscle tone and stiffness (spasticity). Baclofen works at the level of the spinal cord and helps relieve this tension.
Common side effects are drowsiness, dizziness and muscle weakness. Stopping suddenly can be dangerous and causes symptoms to return.
Tizanidine ProveniIncluded in official guidelines, or approved by EMA or FDA
Tizanidine is an alpha-2 agonist that also reduces spasticity. It is often used when baclofen does not work well or is not tolerated.
Side effects are dizziness, fatigue and dry mouth. Here too, gradual tapering is necessary rather than stopping abruptly.
Botulinum toxin ProveniIncluded in official guidelines, or approved by EMA or FDA
Botulinum toxin is injected locally into muscles and temporarily paralyzes them by blocking the release of acetylcholine. This reduces spasticity in certain muscle groups, especially in the arms and legs. The effect is limited to a few months.
The injection itself can cause local discomfort. General side effects are rare but can include weakness in nearby muscles.
Muscle strengthening and mobility
Physiotherapy and exercise therapy ProveniIncluded in official guidelines, or approved by EMA or FDA
Structured exercise therapy helps maintain muscle strength and endurance. In PLS, preference is usually given to moderate, regular exercise, as overly intense exertion can be harmful.
Physiotherapists adapt the exercises to the stage of the disease and individual capabilities.
Occupational therapy and adaptations ProveniIncluded in official guidelines, or approved by EMA or FDA
Occupational therapists assist with adapted living environments, supportive devices (such as splints, armchairs) and aids for daily living. This contributes to independence and safety.
Assistive technology and aids
Supportive aids for mobility ProveniIncluded in official guidelines, or approved by EMA or FDA
Depending on the stage, this can include walking sticks, walking frames, adapted stairlifts, rollators or electric wheelchairs. These help maintain mobility and safety.
Speech and swallowing assistance ProveniIncluded in official guidelines, or approved by EMA or FDA
As the disease progresses, speech and swallowing can become difficult. Speech support devices and adapted food (chopped, puréed) help maintain communication and nutritional intake. Sometimes a feeding tube (PEG tube) is considered.
Pain and symptom management
Paracetamol and NSAIDs ProveniIncluded in official guidelines, or approved by EMA or FDA
Pain, stiffness and cramps can occur. Simple painkillers are tried first. NSAIDs (such as ibuprofen) can help with inflammation and pain.
Side effects and contraindications depend on individual characteristics and other medication use.
Magnesium and quinine supplements ResearchediPositive results in clinical studies, not yet standard treatment
Magnesium and quinine supplements have been investigated for muscle cramps. Efficacy is mixed, but some patients report relief.
Quinine supplements can cause heart rhythm disorders and must be used carefully.
Experimental approaches
Stem cell therapy ExperimentaliOngoing in study setting, outcome still unknown
Research into stem cells (including from bone marrow and fat) and their derivatives is underway. Recent reviews examine safety and efficacy in animal models and early clinical phases. Many studies are still ongoing, no standard treatment.
Side effects and long-term effects are not yet fully understood.
Antisense oligonucleotides and gene targeting techniques ExperimentaliOngoing in study setting, outcome still unknown
These molecules target harmful proteins such as TDP-43. Studies show effects in preclinical research and animal models. Clinical applications in PLS are still being investigated.
Potential side effects include inflammatory reactions and lysosomal changes (which can be seen when examining nerve tissue).
Immunotherapy ExperimentaliOngoing in study setting, outcome still unknown
Because there is evidence that immune activation plays a role, immunosuppressive strategies are being investigated. Research also examines whether certain mimics of PLS (such as anti-IgLON5 disease) do respond to immune treatment.
This is still in preclinical and early clinical phase.
Supportive care
Multidisciplinary teams ProveniIncluded in official guidelines, or approved by EMA or FDA
Hospitals and clinics specialize in motor neuron diseases and work with teams of neurologists, physiotherapists, speech therapists and social workers. This approach improves symptom management and quality of life.
Psychological support ProveniIncluded in official guidelines, or approved by EMA or FDA
Because PLS is progressive and can greatly change daily life, anxiety and depression may develop. Conversations with psychologists or counselors help with this.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._